SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: arizzzona who wrote (9802)6/14/2002 4:29:03 PM
From: padco  Read Replies (1) of 14101
 
Bravo,Dimethaid

I'll second that, arizzzona.

Again Rebecca strikes with a gutsey move. Even if Provalis has some contractual defense against REK's claims, which seems unlikely, the publicity will be positive. The value of Pennsaid will be highlighted as Provalis fights to keep it.

For those of us who reserve the right of skepticism about J n J's commitment to Dimethaid, this U.K. situation could be an acid test. In North America, so the story goes, JnJ will not publicly commit until regulatory approval is given. No such problem is present in the U.K., therefore what would prevent JnJ from marketing Pennsaid over there.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News